Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxiracetam for prevention of postoperative delirium in elderly laparoscopic gastrointestinal surgery patients
ChiCTR2300076112Phase 4Recruiting
- Sponsor
- Hebei Yanda Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Oxiracetam in postoperative delirium (POD) (3 arms), sponsored by Hebei Yanda Hospital. Primary endpoint: Neurocognitive function. Started Jan 2022; status: recruiting.
02
Drugs
Oxiracetam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300076112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076112.